The prevention of contrast-mediated nephropathy (CMN), which accounts for considerable morbidity and mortality, remains a vexing problem. Contrast induced renal vasoconstriction is believed to play a pivotal role in the CMN mechanism. The aim of this study is to examine the efficacy of the prostacyclin analogue iloprost (dose 1ng/kg/min) in preventing CMN in high-risk patients undergoing a coronary procedure.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
208
Iloprost 1ng/kg/min IV starting 1 hour before the procedure and continuing for 4 hours after its end
Placebo IV (Normal saline) starting 1 hour before the procedure and continuing for 4 hours after its end
Onassis Cardiac Surgery Centre
Athens, Greece
CMN is defined as an absolute increase of serum creatinine concentration of at least 0.5 mg/dl
Time frame: 2-5 days after the procedure
or CMN is defined as a relative rise of at least 25% from baseline on the follow-up
Time frame: blood sample drawn at 2-5 days after the procedure
Differences in the progression of serum creatinine concentrations and creatinine clearance among the study groups
Time frame: 2-5 days after the procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.